Caughey Elaine 4
4 · Kymera Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Caughey Elaine
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-21+100,000→ 100,000 totalExercise: $47.56Exp: 2031-06-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares underlying this stock option shall vest on June 21, 2022, and the remainder shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.